Rockland Trust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.5M Buy
68,467
+1,307
+2% +$485K 1.04% 26
2026
Q1
$19.7M Buy
67,160
+2,852
+4% +$937K 0.79% 40
2025
Q4
$22.5M Buy
64,308
+63,538
+8,252% +$21.5M 0.89% 35
2025
Q3
$249K Buy
770
+3
+0.4% +$933 0.01% 278
2025
Q2
$298K Sell
767
-106
-12% -$42.6K 0.01% 219
2025
Q1
$380K Buy
873
+278
+47% +$112K 0.02% 198
2024
Q4
$219K Sell
595
-7
-1% -$2.93K 0.01% 259
2024
Q3
$313K Buy
602
+95
+19% +$50.8K 0.02% 232
2024
Q2
$275K Buy
507
+52
+11% +$27.5K 0.01% 257
2024
Q1
$236K Sell
455
-46
-9% -$22.9K 0.01% 267
2023
Q4
$236K Buy
501
+16
+3% +$7.4K 0.01% 267
2023
Q3
$211K Buy
+485
New +$220K 0.01% 277
2023
Q1
Sell
-495
Closed -$254K 300
2022
Q4
$254K Sell
495
-32
-6% -$16.2K 0.02% 256
2022
Q3
$239K Buy
527
+25
+5% +$12K 0.02% 249
2022
Q2
$242K Buy
+502
New +$248K 0.02% 257

Other funds holding ELV

Rockland Trust's ELV Position: Q2 2026 in Review

Rockland Trust increased its Elevance Health (ELV) stake by 1.9% in Q2 2026, buying an estimated $485K and bringing the position to 68,467 shares worth $26.5M. The position accounts for 1.04% of the portfolio, ranked #26.

Rockland Trust first reported a position in ELV in Q2 2022 and has held it in 15 quarters since. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Rockland Trust held 68,467 shares of Elevance Health worth $26.5M as of Q2 2026.
  • Rockland Trust bought 1,307 Elevance Health shares in Q2 2026, an estimated $485K.
  • Elevance Health made up 1.04% of Rockland Trust's portfolio in Q2 2026, its #26 holding.
  • Rockland Trust first reported a position in Elevance Health in Q2 2022 and has held it in 15 quarters since.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Rockland Trust's 13F filing for Q2 2026, filed 8 Jul 2026.